C07D295/30 - CPC Classification Index

ClassID:

94895 ⎘

C07D295/30 - CPC Classification

Classification description:

Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms; Nitrogen atoms non-acylated

Recent Application in this class:

20240391872

2024-11-28

PHENOXY-ACETYL-THIOUREIDO-BENZENESULFONAMIDE DERIVATIVES, AND THEIR USES

20190135782

2019-05-09

Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders

20190106396

2019-04-11

Bis-diazeniumdiolate compounds as anti-cancer agents

20180251426

2018-09-06

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

20180230092

2018-08-16

NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION

20180170846

2018-06-21

Resorcinol derivatives

20170349539

2017-12-07

Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance

20170233370

2017-08-17

Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders

20160376211

2016-12-29

Cannabidinoid derivatives

#10

20160324781

2016-11-10

Lipids and compositions for intracellular delivery of biologically active compounds

#11

20160073629

2016-03-17

Hydrazinyl lipidoids and uses thereof

#12

20160024004

2016-01-28

Antiviral agents against HBV infection

#13

20150274647

2015-10-01

Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance

#14

20150183775

2015-07-02

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#15

20150079035

2015-03-19

Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders

#16

20150050295

2015-02-19

Lipids and compositions for intracellular delivery of biologically active compounds

#17

20140309196

2014-10-16

Piperazine derivatives

#18

20140187531

2014-07-03

Apoptosis promoters

#19

20140162962

2014-06-12

Lipids and compositions for intracellular delivery of biologically active compounds

#20

20140162934

2014-06-12

Lipids and compositions for intracellular delivery of biologically active compounds

#21

20140088106

2014-03-27

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#22

20140066621

2014-03-06

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#23

20130331392

2013-12-12

Cycloalkyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#24

20130209483

2013-08-15

Resorcinol derivatives

#25

20120295832

2012-11-22

Lipids and compositions for intracellular delivery of biologically active compounds

#26

20120149707

2012-06-14

Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same

#27

20120129816

2012-05-24

Aryl sulfonamide amine compounds and their use as 5-HT6 ligands

#28

20120095004

2012-04-19

Sphingosine kinase inhibitors

#29

20110294814

2011-12-01

Compounds for treating proliferative disorders

#30

20110256129

2011-10-20

Apoptosis promoters

#31

20110144112

2011-06-16

Apoptosis promoters

#32

20100298323

2010-11-25

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#33

20100248355

2010-09-30

METHODS FOR GENERATING HIGH TITER HELPER-FREE PREPARATIONS OF RELEASED RECOMBINANT AAV VECTORS

#34

20100240715

2010-09-23

Apoptosis promoters

#35

20100160322

2010-06-24

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#36

20090181949

2009-07-16

1H-imidazole derivative having CB, agonistic, CBpartial agonistic or CBantagnistic activity

#37

20090042855

2009-02-12

Benzamide mGluR5 positive allosteric modulators and methods of making and using same

#38

20080317806

2008-12-25

Antiparasitic Compounds

#39

20080306274

2008-12-11

Method for preparing N-aminopiperidine and its salts

#40

20080306273

2008-12-11

Process for the Preparation of 1-Aminopiperidine Derivatives

#41

20080255169

2008-10-16

Sulphonamide Derivatives

#42

20080214646

2008-09-04

Novel Nsaids Possessing a Nitric Oxide Donor Diazen-1-Ium-1,2-Diolate Moiety

#43

20080206812

2008-08-28

Methods for generating high titer helper-free preparations of released recombinant AAV vectors

#44

20080167352

2008-07-10

Sphingosine kinase inhibitors

#45

20080090782

2008-04-17

Materials and methods to potentiate cancer treatment

#46

20070249829

2007-10-25

Method for the synthesis of exocyclic derivatives of cycloalkyl-hydrazines and exocyclic derivatives of heterocycloalkyl-hydrazines

#47

20070244108

2007-10-18

Phenylsulfonamide Derivatives for Use as 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors

#48

20070238700

2007-10-11

N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES

#49

20070173648

2007-07-26

METHOD FOR PREPARING N-AMINOPIPERIDINE AND ITS SALTS

#50

20070161675

2007-07-12

Processes for hydrazine addition to acrylic macromonomers and products therefrom

#51

20070072860

2007-03-29

Apoptosis promoters

#52

20070015787

2007-01-18

Apoptosis promoters

#53

20060287317

2006-12-21

Sphingosine kinase inhibitors

#54

20060258657

2006-11-16

Apoptosis promoters

#55

20060178490

2006-08-10

Catalysts containing N-pyrrolyl substituted nitrogen donors

#56

20060128706

2006-06-15

Apoptosis promoters

#57

20060057194

2006-03-16

Cationic liposomes for gene transfer

#58

20050266567

2005-12-01

Methods for generating high titer helper-free preparations of released recombinant AAV vectors

#59

20050214249

2005-09-29

O-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates

#60

20050143372

2005-06-30

Compounds, pharmaceutical compositions and methods of use therefor

#61

20050090381

2005-04-28

Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors

#62

20050080088

2005-04-14

Sulfonyl group containing compounds and their use for the treatment of erectile dysfunction

#63

20050054856

2005-03-10

Catalysts containing N-pyrrolyl substituted nitrogen donors

#64

20050054679

2005-03-10

1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity

#65

20050033005

2005-02-10

Sulfonamide anions as catalysts for NCO oligomerization